Tenax Therapeutics (TENX) EBITDA (2010 - 2026)
Tenax Therapeutics (TENX) EBITDA from Jul 31, 2010 to Mar 31, 2026. The TTM Tenax Therapeutics (TENX) EBITDA is -$58M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Tenax Therapeutics (TENX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +122.73% |
| 10 Years TTM | +11.01% |
Annual EBITDA change of Tenax Therapeutics (TENX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$16M | -70.11% |
| 2025 | -$53M | +169.88% |
| 2024 | -$19M | +136.82% |
| 2023 | -$8.23M | -174.41% |
| 2022 | $11M | -133.80% |
| 2021 | -$33M | -431.51% |
| 2020 | $9.87M | -215.44% |
| 2019 | -$8.55M | +24.27% |
| 2018 | -$6.88M | -25.14% |
| 2017 | -$9.19M | -82.54% |
| 2016 | -$53M | +258.76% |
| 2015 | -$15M | -10.87% |
| 2014 | -$16M | +226.59% |
| 2013 | -$5.04M | -37.08% |
| 2012 | -$8.01M | -173.69% |
| 2011 | $11M | +108.24% |
| 2010 | $5.22M | N/A |